Gupta Amit 4

What Happened
Amit Gupta, CEO of Cardlytics (CDLX), was granted 1,500,000 restricted stock units (RSUs) on February 27, 2026. The award is reported as a derivative grant (transaction code A) at a $0.00 per‑share price; the filing does not state a cash purchase. The dollar value of the award is not specified in the Form 4 and will depend on Cardlytics’ share price when RSUs settle.

Key Details

• Transaction date: 2026-02-27; Report filed: 2026-03-03.
• Grant: 1,500,000 RSUs at $0.00 (derivative award).
• Shares owned after transaction: not specified in the provided filing.
• Footnotes: F1 — each RSU equals a contingent right to one share; F2 — RSUs vest in equal amounts quarterly over two years through April 1, 2028, subject to continued employment.
• No 10b5-1 plan, tax‑withholding sale, or late‑filing flag is noted here; filing was made four days after the transaction date — investors may check EDGAR for timeliness status.

Context
RSUs are compensation that convert to actual shares only when they vest and are settled; they do not represent immediate cash or voting shares until delivery. Such grants are common as executive compensation and do not by themselves signal a buy or sell decision by the insider. If/when RSUs vest and are settled, there may be tax withholding or share-withholding arrangements not detailed in this Form 4.